Arrowhead Research | ARWR - Чистый доход





Чистый доход Изменить Дата
Agios Pharmaceuticals USD -99.11M 8.93M 2026-03
Alnylam Pharmaceuticals USD 164.49M 41.5M 2026-06
Anika Therapeutics USD 292K 2.62M 2025-12
Arrowhead Research USD -194.28M 61.55M 2026-06
Heron Therapeutics USD -2.95M 14.54M 2025-12
Incyte USD 585.6M 282.27M 2026-06
Ionis Pharmaceuticals USD -114.65M 21.65M 2026-06
Ligand Pharmaceuticals USD 48.51M 61.85M 2026-06
Merck USD -1.34B 2.9B 2026-06
Moderna USD -1.34B 517M 2026-03
Nektar Therapeutics USD -44.9M 8.82M 2026-03
Novartis USD 3.26B 108M 2026-06
Sarepta Therapeutics USD 330.96M 743.18M 2026-03
TG Therapeutics USD 7.78M 12M 2026-06
Ultragenyx Pharmaceutical USD -185M 56M 2026-03
Vertex Pharmaceuticals USD 1.1B 68.4M 2026-06
Xencor USD -21.73M 107.19M 2026-06